185 related articles for article (PubMed ID: 36245277)
1. The Fifth International Workshop on the Evaluation and Management of Primary Hyperparathyroidism.
Bilezikian JP; Khan AA; Clarke BL; Mannstadt M; Potts JT; Brandi ML
J Bone Miner Res; 2022 Nov; 37(11):2290-2292. PubMed ID: 36245277
[No Abstract] [Full Text] [Related]
2. Evaluation and treatment of primary hyperparathyroidism.
Grey A; Bolland M; Reid IR
JAMA; 2005 Dec; 294(21):2699-700. PubMed ID: 16333003
[No Abstract] [Full Text] [Related]
3. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.
Bilezikian JP; Khan AA; Potts JT;
J Clin Endocrinol Metab; 2009 Feb; 94(2):335-9. PubMed ID: 19193908
[TBL] [Abstract][Full Text] [Related]
4. The diagnosis and management of asymptomatic primary hyperparathyroidism revisited.
Khan AA; Bilezikian JP; Potts JT;
J Clin Endocrinol Metab; 2009 Feb; 94(2):333-4. PubMed ID: 19193907
[No Abstract] [Full Text] [Related]
5. Primary hyperparathyroidism: diagnosis and management in 2017.
Syed H; Khan A
Pol Arch Intern Med; 2017 Jun; 127(6):438-441. PubMed ID: 28533500
[TBL] [Abstract][Full Text] [Related]
6. Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.
Marcocci C; Brandi ML; Scillitani A; Corbetta S; Faggiano A; Gianotti L; Migliaccio S; Minisola S
J Endocrinol Invest; 2015 May; 38(5):577-93. PubMed ID: 25820553
[No Abstract] [Full Text] [Related]
7. Asymptomatic primary hyperparathyroidism--commentary on current management.
Khan A
J Clin Densitom; 2010; 13(4):321-3. PubMed ID: 21029970
[No Abstract] [Full Text] [Related]
8. Diagnosis and Management of Primary Hyperparathyroidism.
Zhu CY; Sturgeon C; Yeh MW
JAMA; 2020 Mar; 323(12):1186-1187. PubMed ID: 32031566
[No Abstract] [Full Text] [Related]
9. A pilot study to examine the management of asymptomatic hyperparathyroidism in Japanese patients in accordance with the guidelines for asymptomatic PHPT proposed at the Third International Workshop in 2008.
Ogo A; Sakaki Y; Saito R; Sakamoto R; Matoba Y
Intern Med; 2014; 53(16):1749-54. PubMed ID: 25130104
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.
Bilezikian JP; Khan AA; Silverberg SJ; Fuleihan GE; Marcocci C; Minisola S; Perrier N; Sitges-Serra A; Thakker RV; Guyatt G; Mannstadt M; Potts JT; Clarke BL; Brandi ML;
J Bone Miner Res; 2022 Nov; 37(11):2293-2314. PubMed ID: 36245251
[TBL] [Abstract][Full Text] [Related]
11. [Primary hyperparathyroidism].
Krysiak R; Okopień B; Herman ZS
Pol Arch Med Wewn; 2005 Oct; 114(4):1016-24. PubMed ID: 16789530
[No Abstract] [Full Text] [Related]
12. Asymptomatic Primary Hyperparathyroidism.
Clarke BL
Front Horm Res; 2019; 51():13-22. PubMed ID: 30641522
[TBL] [Abstract][Full Text] [Related]
13. Management of normocalcemic primary hyperparathyroidism.
Cusano NE; Cipriani C; Bilezikian JP
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):837-845. PubMed ID: 30665550
[TBL] [Abstract][Full Text] [Related]
14. Hyperparathyroidism.
Bilezikian JP; Bandeira L; Khan A; Cusano NE
Lancet; 2018 Jan; 391(10116):168-178. PubMed ID: 28923463
[TBL] [Abstract][Full Text] [Related]
15. Primary hyperparathyroidism.
Kelly KJ; Chen H; Sippel RS
Cancer Treat Res; 2010; 153():87-103. PubMed ID: 19957221
[No Abstract] [Full Text] [Related]
16. [Problems of diagnosis and therapy of primary hyperparathyroidism--case report].
Podwińska E; Skorupa A; Ziółko E; Turek S; Adamkiewicz K; Mazur J
Pol Merkur Lekarski; 2011 Sep; 31(183):168-70. PubMed ID: 21991847
[TBL] [Abstract][Full Text] [Related]
17. Managing primary hyperparathyroidism in primary care.
Drug Ther Bull; 2010 Mar; 48(3):30-3. PubMed ID: 20200146
[TBL] [Abstract][Full Text] [Related]
18. An overview of normocalcemic primary hyperparathyroidism.
Pawlowska M; Cusano NE
Curr Opin Endocrinol Diabetes Obes; 2015 Dec; 22(6):413-21. PubMed ID: 26512768
[TBL] [Abstract][Full Text] [Related]
19. [News in endocrinology: Management of asymptomatic primary hyperparathyroidism in 2014].
Köhler BB; Philippe J
Rev Med Suisse; 2015 Jan; 11(456-457):58-61. PubMed ID: 25799652
[TBL] [Abstract][Full Text] [Related]
20. Letter to the editor: Distinguishing typical primary hyperparathyroidism from familial hypocalciuric hypercalcemia by using an index of urinary calcium.
Marx SJ
J Clin Endocrinol Metab; 2015 Feb; 100(2):L29-30. PubMed ID: 25658165
[No Abstract] [Full Text] [Related]
[Next] [New Search]
